78.2 F
New York
Tuesday, June 6, 2023



Mirror Biologics Announces Appointment of Dr. David Fineberg as Chief Medical Officer

Related Articles

CannaBabe, a Pioneering Force in the Cannabis Industry, Hosted a Remarkable Event to Kick Off Detroit’s Memorial Weekend with Sunset Techno

Detroit, MI, June 06, 2023 --(PR.com)-- CannaBabe, a pioneering force in the cannabis industry, hosted a remarkable event to kick off Detroit’s Memorial Weekend.“Sunset Techno”...

Dr. Jennifer Ripton-Snyder Joins New York Imaging Specialists

Port Jefferson, NY, June 06, 2023 --(PR.com)-- New York Imaging Specialists is thrilled to announce the addition of Dr. Jennifer Ripton-Snyder, a fellowship-trained breast imager....
Tampa, FL, December 26, 2021 –(PR.com)– Mirror Biologics, Inc., a clinical stage immunotherapy company specializing in the development, manufacturing, commercialization and clinical translation of next generation immunomodulatory and therapeutic in-situ vaccines for cancer and infectious diseases, today announced the appointment of David Fineberg, MD, MBA, as Chief Medical Officer effective January 1, 2022.

Dr. Fineberg brings to the Company more than 18 years’ experience in the pharmaceutical industry with extensive experience in clinical development, regulatory affairs, pharmacovigilance and quality systems. Dr. Fineberg will oversee global clinical development activities for the patented “off-the-shelf,” non-genetically manipulated patented T cell product, AlloStim®, as well as managing the launch of new indications and future generations of this drug. Initial focus will be on accelerating current late stage clinical trials…

Read more…

Popular Articles